IRCCS Humanitas Research Hospital

InstitutionResearch output, impact & collaborations

IRCCS Humanitas Research Hospital is a research organisation in Rozzano, IT. OpenAlex records 16,898 works and 993,669 citations for it. 4,269 researchers list it as their most recent affiliation.

16,898

Works

993,669

Citations

4,269

Researchers

Avg h-index

IDs:ROR OpenAlex

How has IRCCS Humanitas Research Hospital's publication output changed over time?

ScholarIQpublication output · 2012–2020

Output grew0% over the shown period — from 1 works in 2012 to 1 in 2020.

201220142016201720182020

What are the most-cited papers on IRCCS Humanitas Research Hospital?

ScholarIQmost cited works

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

Chris Estes, Quentin M. Anstee, M. Arias, Heike Bantel, Stefano Bellentani, Joan Caballería, Massimo Colombo, Antonio Craxı̀, Javier Crespo, Christopher P. Day, Yuichiro Eguchi, Andreas Geier, Loreta A. Kondili, Daniela C. Kroy, Jeffrey V. Lazarus, Rohit Loomba, Michael P. Manns, Giulio Marchesini, Atsushi Nakajima, Francesco Negro, Salvatore Petta, Vlad Ratziu, Manuel Romero‐Gómez, Arun J. Sanyal, Jörn M. Schattenberg, Frank Tacke, Junko Tanaka, Christian Trautwein, Lai Wei, Stefan Zeuzem, Homie Razavi

Journal of Hepatology. 20182,031 CitationsOPEN ACCESS

Ceritinib in <i>ALK</i> -Rearranged Non–Small-Cell Lung Cancer

Alice T. Shaw, Dong-Wan Kim, Ranee Mehra, Daniel S.W. Tan, Enriqueta Felip, Laura Q.M. Chow, D. Ross Camidge, Johan Vansteenkiste, Sunil Sharma, Tommaso De Pas, Gregory J. Riely, Benjamin Solomon, Juergen Wolf, Michael Thomas, Martin Schüler, Geoffrey Liu, Armando Santoro, Yvonne Lau, Meredith A. Goldwasser, Anthony Boral, Jeffrey A. Engelman

New England Journal of Medicine. 20141,477 Citations

Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer

Kevin C. Conlon, Enrico Lugli, Hugh C. Welles, Steven A. Rosenberg, Antonio Tito Fojo, John C. Morris, Thomas A. Fleisher, Sigrid Dubois, Liyanage P. Perera, Donn M. Stewart, Carolyn K. Goldman, Bonita R. Bryant, Jean M. Decker, Jing Chen, Tatyana Worthy, William D. Figg, Cody J. Peer, Michael C. Sneller, H. Clifford Lane, Jason L. Yovandich, Stephen P. Creekmore, Mario Roederer, Thomas A. Waldmann

Journal of Clinical Oncology. 2014714 CitationsOPEN ACCESS

Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial

José Trigo, Vivek Subbiah, Benjamin Besse, Víctor Moreno, Rafael López‐López, María Ángeles Sala, Solange Peters, Santiago Ponce, Cristian Fernández, Vicente Alfaro, Javier Gómez, Carmen Kahatt, Ali Zeaiter, Khalil Zaman, Valentina Boni, Jennifer Arrondeau, Maite Martínez, Jean‐Pierre Delord, Ahmad Awada, Rebecca Kristeleit, M.E. Olmedo, Luciano Wannesson, Javier Valdivia, María Jesús Rubio, Antonio Antón, John Sarantopoulos, Sant P. Chawla, Joaquín Mosquera, M. D’Arcangelo, Armando Santoro, Víctor M. Villalobos, Jacob Sands, Luis Paz‐Ares

The Lancet Oncology. 2020476 Citations

Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial

Dong‐Wan Kim, Ranee Mehra, Daniel S.W. Tan, Enriqueta Felip, Laura Q.M. Chow, D. Ross Camidge, Johan Vansteenkiste, Sunil Sharma, Tommaso De Pas, Gregory J. Riely, Benjamin Solomon, Jürgen Wolf, Michael Thomas, Martin Schüler, Geoffrey Liu, Armando Santoro, Santosh Sutradhar, Siyu Li, Tomasz Szczudlo, A. Yovine, Alice T. Shaw

The Lancet Oncology. 2016470 CitationsOPEN ACCESS